disease tissues [7, 8] . Phylogenetic analysis of this sequence suggested that the Whipple bacillus is an actinomycete and prompted the proposal of a new taxon, Tropheryma whippelii [8] . The T. whippelii ssu rDNA sequence now provides the basis for a specific PCR detection assay [8] [9] [10] [11] . Armed with this diagnostic tool, Schoedon et al. [12] have tested a clever approach for in vitro Whipple bacillus propagation. The outcome of host infection depends in part upon a complex, local interplay of immune effector cells and cytokines. Pathogens often manipulate these host immune responses to render the local environment more hospitable and to enhance their survival or dissemination [13] ; one strategy is to alter the local ThlZTh2 helper T cell profile. Suppression of tumor necrosis factor-a or interferon (IFN)-y-mediated macrophage activation is a common strategy for microorganisms that choose an intracellular niche. Might one mimic this strategy by treating macrophages with cytokines or hormones that deactivate microbicidal pathways but preserve phagocytosis and thereby promote replication of an organism in a protected intracellular compartment? Interleukin (IL)-4, IL-10, and dexamethasone have been shown to enhance intracellular growth of certain pathogens within human macrophages by suppressing both oxidative and nonoxidative killing mechanisms but without inhibiting bacterial uptake [ However, quantitative PCR methods with internal standards would provide a more direct and reliable assessment of bacterial growth in this situation [16] .
The exact identity of the organism propagated in this study is another crucial issue. Heart-valve tissue with apparently typical Whipple's disease pathology, from 2 persons, served as the inocula for cultivation [12] . From each tissue sample, a partial bacterial 16S rDNA fragment was amplified using broad-range PCR, from which ?400 bp of sequence was determined. Although these sequences were nearly identical to the corresponding segment of the previously published T. whippelii 16S rDNA sequence [8] , this amount of primary sequence information is less than desirable. At various stages of tissue cocultivation, a T whippelii PCR-based assay was positive, but the details of assay specificity are not provided. For the purpose of species, and certainly strain, identification, a complete 16S rDNA sequence is probably a minimum requirement; in most cases, additional sequence information from more rapidly evolving genetic loci is necessary. Nonetheless, it appears quite likely that the organism propagated by Schoedon In an era of decreasing reliance on cultivated organisms and increasing reliance on rapid and specific molecular or sequencebased methods for microbial characterization, what is the value of propagating an organism such as the Whipple bacillus in the laboratory? With phylogenetically useful sequence alone, microbial identification and evolutionary analysis are possible; predictions can be made regarding metabolic, biochemical, and virulence-associated activities and then further evaluated with consensus PCR and sequencing; growth state might be estimated from quantitative rRNA measurements; and compelling arguments can be developed for a role in disease causation [19] . To the degree that additional genome sequence information may be further revealing, one might "walk" the chromosome of an uncultivated microorganism beginning with the ssu rDNA [20] ; it may even be possible to determine a complete genome sequence from such organisms with shotgun cloning methods and powerful sequence assembly algorithms. However, the advantages of a laboratory propagated organism are still substantial.
A viable microorganism, provided with relevant growth conditions, readily reveals its metabolic and virulence capabilities. Disease models and correlates of pathogenicity can be established. Laboratory propagation creates substantial amounts of pure microbial cell mass, with which serologic assays can be developed, monoclonal antibodies elicited, and chromosomal DNA easily prepared. From recombinant chromosomal libraries, virulence-associated genes can be isolated, and the molecular mechanisms of disease causation can be explored. Immunodominant antigens can be cloned and expressed. Diagnosis can then be based on whole cell-or recombinant antigen-based serologic assays or on specific immunochemical and immunofluorescent tissue hybridization. Microbial drug susceptibility can be assessed in vitro. Recombinant antigens may be protective for susceptible hosts.
In theory, all of these advantages can now be realized for T. whippelii. In practice, several issues will first need to be addressed. The organism propagated by these authors should be characterized in greater detail. Optimization of growth conditions leading to consistent, high-titer culture yields will be important. One approach might involve cell lines bearing transgenes or genetic defects that render them hypersusceptible to T whippelii growth. Intracellular bacterial degradation needs to be minimized. And, of course, the findings reported herein need to be reproduced by others. But if this work is substantiated, Schoedon and colleagues will have made a key contribution to a fascinating 90-year saga in clinical microbiology. No microorganism is uncultivatible; the real issue is whether we are intelligent enough to understand the sometimes complex and intimate growth requirements of our prokaryotic cousins.
